Kelly McKee

Kelly McKee

Chief Tech/Sci/R&D Officer at GEOVAX LABS, INC.

Net worth: 4 772 $ as of 2024-03-30

74 year
Commercial Services
Consumer Services
Technology Services

Profile

Kelly T.
McKee
is currently the Chief Medical Officer at GeoVax Labs, Inc. Previously, Kelly held positions such as Operations Director at Quintiles Transnational Corp., Senior Director-Clinical Research at DynPort Vaccine Co. LLC, Vice President-Vaccines & Public Health at IQVIA, Inc., Chief Medical Officer at Pharm-Olam International Ltd., and Chief Medical Officer at Bravovax Co., Ltd.
Kelly received an undergraduate degree from Davidson College, a graduate degree from The Johns Hopkins University, and a doctorate degree from The University of Virginia School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-10 2,386 ( 0.11% ) 4 772 $ 2024-03-30

Kelly McKee active positions

CompaniesPositionStart
GEOVAX LABS, INC. Chief Tech/Sci/R&D Officer 2022-01-05
All active positions of Kelly McKee

Former positions of Kelly McKee

CompaniesPositionEnd
IMS HEALTH, INC. Corporate Officer/Principal -
Bravovax Co., Ltd. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Chief Operating Officer -
See the detail of Kelly McKee's experience

Training of Kelly McKee

Davidson College Undergraduate Degree
The Johns Hopkins University Graduate Degree
The University of Virginia School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kelly McKee's experience

Connections

11

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Commercial Services

Technology Services

Commercial Services

GeoVax Labs, Inc.

Commercial Services

Bravovax Co., Ltd.

See company connections